Cargando…

TTF-1、CD56、P40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究

BACKGROUND AND OBJECTIVE: The aim of this study is to explore roles of thyroid transcription factor-1 (TTF-1), CD56, P40 expression and other clinical characteristics predicting response and survival in patients with small cell lung cancer (SCLC). METHODS: Formalin-fixed, paraffin-embedded biopsy ti...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973008/
https://www.ncbi.nlm.nih.gov/pubmed/28855032
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.08.04
_version_ 1783326523031289856
collection PubMed
description BACKGROUND AND OBJECTIVE: The aim of this study is to explore roles of thyroid transcription factor-1 (TTF-1), CD56, P40 expression and other clinical characteristics predicting response and survival in patients with small cell lung cancer (SCLC). METHODS: Formalin-fixed, paraffin-embedded biopsy tissues were retrospectively obtained from 198 SCLC patients who were diagnosed first in Xuanwu Hospital. The expressions of TTF-1, CD56 and P40 were detected by immunohistochemistry. The clinical data including age, gender, cancer stage, Eastern Cooperative Oncology Group (ECOG) score, smoking or not, superior vena cava syndrome (SVCS) due to lung cancer or not were collected. Cox proportional hazard model was used to analyze the relationship between the overall survival (OS) and factors. RESULTS: Immunohistochemical staining results showed the positive rate of TTF-1, CD56, P40 were 73.2%, 88.4% and 7.1% respectively. TTF-1 expression (OR=0.665, 95%CI: 0.472-0.937), smoking index ≤400 (OR=1.72, 95%CI: 1.061-2.789) and ECOG=2 (OR=3.551, 95%CI: 2.133-5.914), extensive-stage (OR=2.487, 95%CI: 1.793-3.451) and SVCS due to lung cancer (OR=2.394, 95%CI: 1.49-3.846) were independent prognostic factors for SCLC patients. CONCLUSION: Prognosis of SCLC was related to TTF-1 expression independently after adjusting smoking, ECOG score, stage and SVCS due to lung cancer. Detection of TTF-1, CD56 and P40 expression level might be helpful for predict the prognosis of SCLC.
format Online
Article
Text
id pubmed-5973008
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59730082018-07-06 TTF-1、CD56、P40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究 Zhongguo Fei Ai Za Zhi 吸烟与肺癌重点号 BACKGROUND AND OBJECTIVE: The aim of this study is to explore roles of thyroid transcription factor-1 (TTF-1), CD56, P40 expression and other clinical characteristics predicting response and survival in patients with small cell lung cancer (SCLC). METHODS: Formalin-fixed, paraffin-embedded biopsy tissues were retrospectively obtained from 198 SCLC patients who were diagnosed first in Xuanwu Hospital. The expressions of TTF-1, CD56 and P40 were detected by immunohistochemistry. The clinical data including age, gender, cancer stage, Eastern Cooperative Oncology Group (ECOG) score, smoking or not, superior vena cava syndrome (SVCS) due to lung cancer or not were collected. Cox proportional hazard model was used to analyze the relationship between the overall survival (OS) and factors. RESULTS: Immunohistochemical staining results showed the positive rate of TTF-1, CD56, P40 were 73.2%, 88.4% and 7.1% respectively. TTF-1 expression (OR=0.665, 95%CI: 0.472-0.937), smoking index ≤400 (OR=1.72, 95%CI: 1.061-2.789) and ECOG=2 (OR=3.551, 95%CI: 2.133-5.914), extensive-stage (OR=2.487, 95%CI: 1.793-3.451) and SVCS due to lung cancer (OR=2.394, 95%CI: 1.49-3.846) were independent prognostic factors for SCLC patients. CONCLUSION: Prognosis of SCLC was related to TTF-1 expression independently after adjusting smoking, ECOG score, stage and SVCS due to lung cancer. Detection of TTF-1, CD56 and P40 expression level might be helpful for predict the prognosis of SCLC. 中国肺癌杂志编辑部 2017-08-20 /pmc/articles/PMC5973008/ /pubmed/28855032 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.08.04 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 吸烟与肺癌重点号
TTF-1、CD56、P40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究
title TTF-1、CD56、P40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究
title_full TTF-1、CD56、P40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究
title_fullStr TTF-1、CD56、P40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究
title_full_unstemmed TTF-1、CD56、P40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究
title_short TTF-1、CD56、P40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究
title_sort ttf-1、cd56、p40免疫组化标志物及其他临床特征与小细胞肺癌预后相关性研究
topic 吸烟与肺癌重点号
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973008/
https://www.ncbi.nlm.nih.gov/pubmed/28855032
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.08.04
work_keys_str_mv AT ttf1cd56p40miǎnyìzǔhuàbiāozhìwùjíqítālínchuángtèzhēngyǔxiǎoxìbāofèiáiyùhòuxiāngguānxìngyánjiū
AT ttf1cd56p40miǎnyìzǔhuàbiāozhìwùjíqítālínchuángtèzhēngyǔxiǎoxìbāofèiáiyùhòuxiāngguānxìngyánjiū
AT ttf1cd56p40miǎnyìzǔhuàbiāozhìwùjíqítālínchuángtèzhēngyǔxiǎoxìbāofèiáiyùhòuxiāngguānxìngyánjiū
AT ttf1cd56p40miǎnyìzǔhuàbiāozhìwùjíqítālínchuángtèzhēngyǔxiǎoxìbāofèiáiyùhòuxiāngguānxìngyánjiū
AT ttf1cd56p40miǎnyìzǔhuàbiāozhìwùjíqítālínchuángtèzhēngyǔxiǎoxìbāofèiáiyùhòuxiāngguānxìngyánjiū
AT ttf1cd56p40miǎnyìzǔhuàbiāozhìwùjíqítālínchuángtèzhēngyǔxiǎoxìbāofèiáiyùhòuxiāngguānxìngyánjiū
AT ttf1cd56p40miǎnyìzǔhuàbiāozhìwùjíqítālínchuángtèzhēngyǔxiǎoxìbāofèiáiyùhòuxiāngguānxìngyánjiū
AT ttf1cd56p40miǎnyìzǔhuàbiāozhìwùjíqítālínchuángtèzhēngyǔxiǎoxìbāofèiáiyùhòuxiāngguānxìngyánjiū